Capital Expenditures for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's current capital expenditures (TTM) is $437.60M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$437.60M
YoY change
+47.0%
5Y CAGR
+11.0%
Peak year (2025)
$437.60M
Cumulative capital expenditures
$2.85B
CapEx history chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2025
CapEx history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $437.60M | +47.0% | ||
| 2024 | $297.70M | +15.2% | ||
| 2023 | $258.40M | +26.2% | ||
| 2022 | $204.70M | -12.9% | ||
| 2021 | $235.00M | -9.5% | ||
| 2020 | $259.80M | +244.3% | ||
| 2019 | $75.45M | -21.0% | ||
| 2018 | $95.52M | -63.2% | ||
| 2017 | $259.42M | +358.6% | ||
| 2016 | $56.56M | +24.9% | ||
| 2015 | $45.30M | -11.5% | ||
| 2014 | $51.20M | -0.4% | ||
| 2013 | $51.39M | -27.8% | ||
| 2012 | $71.14M | -24.8% | ||
| 2011 | $94.59M | +148.6% | ||
| 2010 | $38.05M | +62.0% | ||
| 2009 | $23.50M | -27.0% | ||
| 2008 | $32.18M | -0.7% | ||
| 2007 | $32.41M | -0.0% | ||
| 2006 | $32.42M | +91.1% | ||
| 2005 | $16.96M | +35.7% | ||
| 2004 | $12.49M | -28.0% | ||
| 2003 | $17.35M | -57.9% | ||
| 2002 | $41.22M | -23.5% | ||
| 2001 | $53.90M | +352.4% | ||
| 2000 | $11.91M | -26.5% | ||
| 1999 | $16.20M | +105.1% | ||
| 1998 | $7.90M | +31.7% | ||
| 1997 | $6.00M | +50.0% | ||
| 1996 | $4.00M | -25.9% | ||
| 1995 | $5.40M | +184.2% | ||
| 1994 | $1.90M | +5.6% | ||
| 1993 | $1.80M | +20.0% | ||
| 1992 | $1.50M | +25.0% | ||
| 1991 | $1.20M | — |
CapEx values are taken from Vertex Pharmaceuticals's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Vertex Pharmaceuticals (VRTX) capital expenditures totalled $437.60M – surged 47.0% year-over-year.
Vertex Pharmaceuticals capital expenditures has grown for 3 consecutive years, with a +11.0% compound annual growth rate over 2020–2025 (5 years).
The highest annual capital expenditures of $437.60M was reported in 2025. The lowest in the available history was $1.20M in 1991.
Vertex Pharmaceuticals (VRTX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Vertex Pharmaceuticals Capital Expenditures by Year
Vertex Pharmaceuticals Capital Expenditures 2025: $437.60M
Vertex Pharmaceuticals capital expenditures in 2025 was $437.60M, surged 47.0% from 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Capital Expenditures 2024: $297.70M
Vertex Pharmaceuticals capital expenditures in 2024 was $297.70M, grew 15.2% from 2023.
Vertex Pharmaceuticals Capital Expenditures 2023: $258.40M
Vertex Pharmaceuticals capital expenditures in 2023 was $258.40M, grew 26.2% from 2022.
Vertex Pharmaceuticals Capital Expenditures 2022: $204.70M
Vertex Pharmaceuticals capital expenditures in 2022 was $204.70M, declined 12.9% below 2021.
Vertex Pharmaceuticals Capital Expenditures 2021: $235.00M
Vertex Pharmaceuticals capital expenditures in 2021 was $235.00M.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — CapEx
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's capital expenditures?
- Latest reported capital expenditures for Vertex Pharmaceuticals (VRTX) is $437.60M (period ending December 31, 2025).
How has Vertex Pharmaceuticals capital expenditures changed year-over-year?
- Vertex Pharmaceuticals (VRTX) capital expenditures changed +47.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals capital expenditures?
- Vertex Pharmaceuticals (VRTX) capital expenditures compound annual growth rate is +11.0% over the most recent 5 years available.
When did Vertex Pharmaceuticals capital expenditures hit its highest annual value?
- Vertex Pharmaceuticals capital expenditures reached its highest annual value of $437.60M in 2025.
What was Vertex Pharmaceuticals capital expenditures in 2024?
- Vertex Pharmaceuticals (VRTX) capital expenditures in 2024 was $297.70M.
What was Vertex Pharmaceuticals capital expenditures in 2025?
- Vertex Pharmaceuticals (VRTX) capital expenditures in 2025 was $437.60M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.